Skip to content Skip to navigation

Bilateral intravitreal injection of antivascular endothelial growth factor therapy.

TitleBilateral intravitreal injection of antivascular endothelial growth factor therapy.
Publication TypeJournal Article
Year of Publication2011
AuthorsMahajan, Vinit B., Elkins Kori A., Russell Stephen R., H Boldt Culver, Gehrs Karen M., Weingeist Thomas A., Stone Edwin M., Abràmoff Michael D., Liu Dawei, and Folk James C.
JournalRetina (Philadelphia, Pa.)
Volume31
Issue1
Pagination31-5
Date Published2011 Jan
KeywordsAged, Aged, 80 and over, Antibodies, Monoclonal, Case-Control Studies, Drug Administration Schedule, Drug Combinations, Female, Follow-Up Studies, Humans, Incidence, Injections, Intraocular, Macular Degeneration, Male, Middle Aged, Myocardial Infarction, Patient Preference, Retrospective Studies, Vascular Endothelial Growth Factor A, Vitreous Body
Abstract

The purpose of this study was to review adverse events and patient preference after bilateral intravitreal injection of antibodies to vascular endothelial growth factor.

Alternate JournalRetina (Philadelphia, Pa.)